T. Croci et al., In vitro functional evidence of different neurotensin-receptors modulatingthe motor response of human colonic muscle strips, BR J PHARM, 127(8), 1999, pp. 1922-1928
1 The newly developed non-peptide neurotensin (NT)-receptor antagonists SR
48692 and SR 142948 were used to challenge NT responses of human colonic ci
rcular smooth muscle strips in vitro. The presence of NT1 and NT2 receptor
transcripts in this tissue was tested by reverse transcriptase polymerase c
hain reaction (RT-PCR) analysis.
2 NT potently and dose-dependently contracted muscle strips, with significa
nt regional differences in potency and efficacy between the transverse and
distal colon: EC50, 3.6 and 7.5 nM; the maximal effect was 70 and 55% of 0.
1 mM carbachol. Colonic responses to NT in both segments were virtually the
same in the presence of atropine (1 mu M), levocabastine (10 mu M) or tetr
odotoxin (1 mu M).
3 SR 142948 (10 nM - 1 mu M) competitively antagonized NT responses in the
transverse and distal colon with similar affinities: pA(2) values 8.71 and
8.45, slopes 0.98 and 0.99. SR 48692 (10 nM-10 mu M) antagonized the NT res
ponse competitively in the distal colon (pA(2) 6.55, slope 0.79) and non-co
mpetitively in the transverse colon (pA(2) 8.0, slope 0.51). Neither compou
nd had any agonist effect.
4 The fact that the specific antagonists prevented NT-evoked atropine- and
tetrodotoxin-insensitive mechanical responses of colonic muscle strips is h
ighly consistent with the presence in these tissues of non-neuronal NT rece
ptors, whose heterogeneity in the transverse segment is supported by the no
n-competitive antagonism of SR 48692. The finding of NT1 receptor transcrip
t in both transverse and distal colon suggests its identity with the lower
affinity site disclosed functionally by SR 48692 in these segments.